{"id":13276,"date":"2018-04-03T11:36:22","date_gmt":"2018-04-03T11:36:22","guid":{"rendered":"http:\/\/www.neurodegenerationresearch.eu\/?p=13276"},"modified":"2022-04-13T08:55:50","modified_gmt":"2022-04-13T08:55:50","slug":"prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model","status":"publish","type":"post","link":"https:\/\/neurodegenerationresearch.eu\/fi\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/","title":{"rendered":"Prognosis for patients with ALS: development and validation of a personalised prediction model"},"content":{"rendered":"<div  class=\"row row-flex\">\n<div class=\"col-lg-8 col-md-8 col-sm-6 col-12\" style=\"align-self: center !important\">\n<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1474442218300899\">&#8220;Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model&#8221;<\/a> has been published in <em>The Lancet Neurology<\/em>. This work was supported in part by JPND thorugh the <a href=\"https:\/\/www.neurodegenerationresearch.eu\/initiatives\/annual-calls-for-proposals\/closed-calls\/biomarkers-transnational-call\/results-of-biomarker-call\/sophia\/\">SOPHIA<\/a>,<br \/>\n<a href=\"https:\/\/www.neurodegenerationresearch.eu\/wp-content\/uploads\/2015\/02\/NETCALS.pdf\">NETCALS<\/a>, and <a href=\"https:\/\/www.neurodegenerationresearch.eu\/initiatives\/annual-calls-for-proposals\/closed-calls\/risk-factors-2012\/risk-factor-call-results\/strength\/\">STRENGTH<\/a> projects.<\/div>\n<div class=\"col-lg-4 col-md-4 col-sm-6 col-12\">\n<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1474442218300899\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-13278\" src=\"https:\/\/www.neurodegenerationresearch.eu\/wp-content\/uploads\/2018\/04\/Lancet-Neurology-300x184.png\" alt=\"\" width=\"300\" height=\"184\" srcset=\"https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2018\/04\/Lancet-Neurology-300x184.png 300w, https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2018\/04\/Lancet-Neurology-768x472.png 768w, https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2018\/04\/Lancet-Neurology-890x547.png 890w, https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2018\/04\/Lancet-Neurology.png 981w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Prognosis for patients with amyotrophic lateral sclerosis: development and validation [&hellip;]<\/p>\n<a href=\"https:\/\/neurodegenerationresearch.eu\/fi\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/\">View Post<\/a>","protected":false},"author":3,"featured_media":13281,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[383],"tags":[],"class_list":["post-13276","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jpnd-publications"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prognosis for patients with ALS: development and validation of a personalised prediction model - JPND Neurodegenerative Disease Research<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/\" \/>\n<meta property=\"og:locale\" content=\"fi_FI\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prognosis for patients with ALS: development and validation of a personalised prediction model - JPND Neurodegenerative Disease Research\" \/>\n<meta property=\"og:description\" content=\"&#8220;Prognosis for patients with amyotrophic lateral sclerosis: development and validation [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/\" \/>\n<meta property=\"og:site_name\" content=\"JPND Neurodegenerative Disease Research\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-03T11:36:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-13T08:55:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2018\/04\/Lancet-Neurology-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"650\" \/>\n\t<meta property=\"og:image:height\" content=\"430\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"jpnd\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@JPNDeurope\" \/>\n<meta name=\"twitter:site\" content=\"@JPNDeurope\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"jpnd\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/nl\\\/2018\\\/04\\\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/nl\\\/2018\\\/04\\\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\\\/\"},\"author\":{\"name\":\"jpnd\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/person\\\/a97e49cae588ead81db59e48a4e63c2a\"},\"headline\":\"Prognosis for patients with ALS: development and validation of a personalised prediction model\",\"datePublished\":\"2018-04-03T11:36:22+00:00\",\"dateModified\":\"2022-04-13T08:55:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/nl\\\/2018\\\/04\\\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\\\/\"},\"wordCount\":50,\"publisher\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/nl\\\/2018\\\/04\\\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/Lancet-Neurology-1.png\",\"articleSection\":[\"JPND Publications\"],\"inLanguage\":\"fi-FI\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/nl\\\/2018\\\/04\\\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\\\/\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/nl\\\/2018\\\/04\\\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\\\/\",\"name\":\"Prognosis for patients with ALS: development and validation of a personalised prediction model - JPND Neurodegenerative Disease Research\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/nl\\\/2018\\\/04\\\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/nl\\\/2018\\\/04\\\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/Lancet-Neurology-1.png\",\"datePublished\":\"2018-04-03T11:36:22+00:00\",\"dateModified\":\"2022-04-13T08:55:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/nl\\\/2018\\\/04\\\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\\\/#breadcrumb\"},\"inLanguage\":\"fi-FI\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neurodegenerationresearch.eu\\\/nl\\\/2018\\\/04\\\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fi-FI\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/nl\\\/2018\\\/04\\\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/Lancet-Neurology-1.png\",\"contentUrl\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/Lancet-Neurology-1.png\",\"width\":650,\"height\":430},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/nl\\\/2018\\\/04\\\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prognosis for patients with ALS: development and validation of a personalised prediction model\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#website\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\",\"name\":\"JPND Neurodegenerative Disease Research\",\"description\":\"Neurodegenerative Disease Research\",\"publisher\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fi-FI\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\",\"name\":\"JPND\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fi-FI\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/logo.png\",\"width\":248,\"height\":129,\"caption\":\"JPND\"},\"image\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/JPNDeurope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/person\\\/a97e49cae588ead81db59e48a4e63c2a\",\"name\":\"jpnd\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fi-FI\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"caption\":\"jpnd\"},\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/fi\\\/author\\\/jpnd\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prognosis for patients with ALS: development and validation of a personalised prediction model - JPND Neurodegenerative Disease Research","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/","og_locale":"fi_FI","og_type":"article","og_title":"Prognosis for patients with ALS: development and validation of a personalised prediction model - JPND Neurodegenerative Disease Research","og_description":"&#8220;Prognosis for patients with amyotrophic lateral sclerosis: development and validation [&hellip;]","og_url":"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/","og_site_name":"JPND Neurodegenerative Disease Research","article_published_time":"2018-04-03T11:36:22+00:00","article_modified_time":"2022-04-13T08:55:50+00:00","og_image":[{"width":650,"height":430,"url":"https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2018\/04\/Lancet-Neurology-1.png","type":"image\/png"}],"author":"jpnd","twitter_card":"summary_large_image","twitter_creator":"@JPNDeurope","twitter_site":"@JPNDeurope","twitter_misc":{"Written by":"jpnd"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/#article","isPartOf":{"@id":"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/"},"author":{"name":"jpnd","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/person\/a97e49cae588ead81db59e48a4e63c2a"},"headline":"Prognosis for patients with ALS: development and validation of a personalised prediction model","datePublished":"2018-04-03T11:36:22+00:00","dateModified":"2022-04-13T08:55:50+00:00","mainEntityOfPage":{"@id":"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/"},"wordCount":50,"publisher":{"@id":"https:\/\/neurodegenerationresearch.eu\/#organization"},"image":{"@id":"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/#primaryimage"},"thumbnailUrl":"https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2018\/04\/Lancet-Neurology-1.png","articleSection":["JPND Publications"],"inLanguage":"fi-FI"},{"@type":"WebPage","@id":"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/","url":"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/","name":"Prognosis for patients with ALS: development and validation of a personalised prediction model - JPND Neurodegenerative Disease Research","isPartOf":{"@id":"https:\/\/neurodegenerationresearch.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/#primaryimage"},"image":{"@id":"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/#primaryimage"},"thumbnailUrl":"https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2018\/04\/Lancet-Neurology-1.png","datePublished":"2018-04-03T11:36:22+00:00","dateModified":"2022-04-13T08:55:50+00:00","breadcrumb":{"@id":"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/#breadcrumb"},"inLanguage":"fi-FI","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/"]}]},{"@type":"ImageObject","inLanguage":"fi-FI","@id":"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/#primaryimage","url":"https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2018\/04\/Lancet-Neurology-1.png","contentUrl":"https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2018\/04\/Lancet-Neurology-1.png","width":650,"height":430},{"@type":"BreadcrumbList","@id":"https:\/\/neurodegenerationresearch.eu\/nl\/2018\/04\/prognosis-for-patients-with-als-development-and-validation-of-a-personalised-prediction-model\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neurodegenerationresearch.eu\/"},{"@type":"ListItem","position":2,"name":"Prognosis for patients with ALS: development and validation of a personalised prediction model"}]},{"@type":"WebSite","@id":"https:\/\/neurodegenerationresearch.eu\/#website","url":"https:\/\/neurodegenerationresearch.eu\/","name":"JPND Neurodegenerative Disease Research","description":"Neurodegenerative Disease Research","publisher":{"@id":"https:\/\/neurodegenerationresearch.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neurodegenerationresearch.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fi-FI"},{"@type":"Organization","@id":"https:\/\/neurodegenerationresearch.eu\/#organization","name":"JPND","url":"https:\/\/neurodegenerationresearch.eu\/","logo":{"@type":"ImageObject","inLanguage":"fi-FI","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.neurodegenerationresearch.eu\/wp-content\/uploads\/2022\/03\/logo.png","contentUrl":"https:\/\/www.neurodegenerationresearch.eu\/wp-content\/uploads\/2022\/03\/logo.png","width":248,"height":129,"caption":"JPND"},"image":{"@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/JPNDeurope"]},{"@type":"Person","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/person\/a97e49cae588ead81db59e48a4e63c2a","name":"jpnd","image":{"@type":"ImageObject","inLanguage":"fi-FI","@id":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","caption":"jpnd"},"url":"https:\/\/neurodegenerationresearch.eu\/fi\/author\/jpnd\/"}]}},"_links":{"self":[{"href":"https:\/\/neurodegenerationresearch.eu\/fi\/wp-json\/wp\/v2\/posts\/13276","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neurodegenerationresearch.eu\/fi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neurodegenerationresearch.eu\/fi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/fi\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/fi\/wp-json\/wp\/v2\/comments?post=13276"}],"version-history":[{"count":0,"href":"https:\/\/neurodegenerationresearch.eu\/fi\/wp-json\/wp\/v2\/posts\/13276\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/fi\/wp-json\/wp\/v2\/media\/13281"}],"wp:attachment":[{"href":"https:\/\/neurodegenerationresearch.eu\/fi\/wp-json\/wp\/v2\/media?parent=13276"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/fi\/wp-json\/wp\/v2\/categories?post=13276"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/fi\/wp-json\/wp\/v2\/tags?post=13276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}